MONTANOVA CAPITAL, LLC bought BNTC
December 22, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 16,650 shares of Benitec Biopharma Inc. at $12.08 per share, a transaction worth $201.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,650
Price
$12.08
Total value
$201.1K
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateDecember 22, 2025
Filing dateDecember 22, 2025
Shares owned after9,577,475
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.